Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Preston Klassen


  • President & Ceo at Metacrine Inc. (MTCR), 2020-09-15
  • Evp And Cmo at Arena Pharmaceuticals Inc (ARNA), 2020-03-03
  • Director at Conatus Pharmaceuticals Inc. (CNAT), 2019-07-01
  • Evp, Global Development at Orexigen Therapeutics Inc. (OREX), 2016-02-04
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ARNA $44.00 3,000 Officer 0 2019-01-08 Filing
ARNA $42.32 400 Officer 0 2019-01-07 Filing
ARNA $41.68 15,600 Officer 400 2019-01-07 Filing
OREX $7.16 71,229 Officer 0 2013-07-25 Filing
OREX $7.21 28,771 Officer 0 2013-05-28 Filing